Please login to the form below

Not currently logged in
Email:
Password:

NDA Group appoints Alison McGregor as its principal consultant

She joins the group following a new US office launch

Drug development consultancy, NDA Group, has appointed Alison McGregor as its principal consultant following the opening of its new US office in San Francisco.

McGregor joins the group from BioMarin Pharmaceuticals, where she was previously global regulatory affairs leader.

She has over 20 years’ experience in the pharmaceutical sector working for both industry and regulatory agencies including AstraZeneca and the UK’s MHRA.

Johan Stromquist, chief executive officer, NDA Group, said: “The US expansion is our main focus in 2018 and we are planning expanding our support for FDA and EMA submissions, milestone meetings and de-risking early stage data packages.

“Bringing Alison on-board is particularly important as her experience represents the ideal we share across NDA – that of bringing diverse regulatory requirements together to create the best possible development programmes as efficiently as possible.”

24th November 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics